112 related articles for article (PubMed ID: 38216091)
1. Loss of the epithelial marker CDX1 predicts poor prognosis in early-stage CRC patients.
Solé L; Lobo-Jarne T; Cabré-Romans JJ; González A; Fernández L; Marruecos L; Guix M; Cuatrecasas M; López S; Bellosillo B; Torres F; Iglesias M; Bigas A; Espinosa L
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119658. PubMed ID: 38216091
[TBL] [Abstract][Full Text] [Related]
2. N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines.
Holst S; Wilding JL; Koprowska K; Rombouts Y; Wuhrer M
Cells; 2019 Mar; 8(3):. PubMed ID: 30909444
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.
Chan CW; Wong NA; Liu Y; Bicknell D; Turley H; Hollins L; Miller CJ; Wilding JL; Bodmer WF
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1936-41. PubMed ID: 19188603
[TBL] [Abstract][Full Text] [Related]
4. Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.
Rönsch K; Jäger M; Schöpflin A; Danciu M; Lassmann S; Hecht A
Epigenetics; 2011 May; 6(5):610-22. PubMed ID: 21393996
[TBL] [Abstract][Full Text] [Related]
5. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
[TBL] [Abstract][Full Text] [Related]
6. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation.
Nakayama C; Yamamichi N; Tomida S; Takahashi Y; Kageyama-Yahara N; Sakurai K; Takeuchi C; Inada KI; Shiogama K; Nagae G; Ono S; Tsuji Y; Niimi K; Fujishiro M; Aburatani H; Tsutsumi Y; Koike K
Cancer Sci; 2018 Dec; 109(12):3853-3864. PubMed ID: 30289576
[TBL] [Abstract][Full Text] [Related]
7. Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression.
Luk IY; Jenkins LJ; Schoffer KL; Ng I; Tse JWT; Mouradov D; Kaczmarczyk S; Nightingale R; Burrows AD; Anderson RL; Arango D; Dopeso H; Croft L; Richardson MF; Sieber OM; Liao Y; Mooi JK; Vukelic N; Reehorst CM; Afshar-Sterle S; Whitehall VLJ; Fennell L; Abud HE; Tebbutt NC; Phillips WA; Williams DS; Shi W; Mielke LA; Ernst M; Dhillon AS; Clemons NJ; Mariadason JM
Cell Death Differ; 2022 Nov; 29(11):2288-2302. PubMed ID: 35606410
[TBL] [Abstract][Full Text] [Related]
8. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
[TBL] [Abstract][Full Text] [Related]
9. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
Wong NA; Britton MP; Choi GS; Stanton TK; Bicknell DC; Wilding JL; Bodmer WF
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):574-9. PubMed ID: 14704280
[TBL] [Abstract][Full Text] [Related]
10. The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiation.
Jones MF; Hara T; Francis P; Li XL; Bilke S; Zhu Y; Pineda M; Subramanian M; Bodmer WF; Lal A
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1550-8. PubMed ID: 25775580
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis.
Mallo GV; Rechreche H; Frigerio JM; Rocha D; Zweibaum A; Lacasa M; Jordan BR; Dusetti NJ; Dagorn JC; Iovanna JL
Int J Cancer; 1997 Feb; 74(1):35-44. PubMed ID: 9036867
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells.
Zhang R; Kang KA; Kim KC; Na SY; Chang WY; Kim GY; Kim HS; Hyun JW
Gene; 2013 Jul; 524(2):214-9. PubMed ID: 23618814
[TBL] [Abstract][Full Text] [Related]
14. A prognostic six-gene expression risk-score derived from proteomic profiling of the metastatic colorectal cancer secretome.
Robles J; Pintado-Berninches L; Boukich I; Escudero B; de Los Rios V; Bartolomé RA; Jaén M; Martín-Regalado Á; Fernandez-Aceñero MJ; Imbaud JI; Casal JI
J Pathol Clin Res; 2022 Nov; 8(6):495-508. PubMed ID: 36134447
[TBL] [Abstract][Full Text] [Related]
15. NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer.
O'Cathail SM; Wu CH; Lewis A; Holmes C; Hawkins MA; Maughan T
Cancer Genet; 2020 Oct; 248-249():1-10. PubMed ID: 32871287
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
17. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
[TBL] [Abstract][Full Text] [Related]
18. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
19. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
